SCHEMBL21899464

SCHEMBL21899464

CC(=O)[C@H](CCCCNC(=O)CCC(C)C)NC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.42
▸ ALB P02768 3/20 0.39
▸ CASP2 P42575 1/20 0.38
▸ FOLH1 Q04609 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ NAMPT P43490 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NAAA Q02083 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ NMT2 O60551 1/20 0.34
▸ NMT1 P30419 1/20 0.34
▸ SIRT5 Q9NXA8 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ SIRT6 Q8N6T7 1/20 0.33
▸ SIRT1 Q96EB6 1/20 0.33
▸ GLP1R P43220 2/20 0.33
▸ BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14952664 0.90 ALDH1A1 (0.41) ALDH1A1ALBCASP2FOLH1LMNA
SCHEMBL23944184 0.88 ALDH1A1 (0.40) ALDH1A1ALBCASP2FOLH1NAAA
SCHEMBL21242815 0.87 FOLH1 (0.41) ALDH1A1ALBCASP2FOLH1GLP1R
SCHEMBL21389121 0.84 CASP2 (0.53) CASP2NAAAMEN1KMT2ASIRT6
SCHEMBL21913856 0.83 ALDH1A1 (0.43) ALDH1A1ALBCASP2FOLH1NAAA
SCHEMBL16248536 0.82 NAMPT (0.40) ALDH1A1ALBCASP2LMNAPKM
SCHEMBL20235708 0.82 KDM4E (0.52) ALDH1A1ALBFOLH1SIRT5TSHR
SCHEMBL29299841 0.82 FOLH1 (0.43) ALDH1A1ALBCASP2FOLH1LMNA
SCHEMBL19239689 0.82 ALDH1A1 (0.55) ALDH1A1CASP2LMNAPKMNAMPT
SCHEMBL24598662 0.81 NAMPT (0.42) ALDH1A1ALBCASP2FOLH1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200121684-A1 MODULATORS OF BTK PROTEOLYSIS AND METHODS OF USE UNIV YALE (US) 2020-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200121684-A1 MODULATORS OF BTK PROTEOLYSIS AND METHODS OF USE BTK, CBL, CRBN ALDH1A1 4291/4885ALB 3733/4885CASP2 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback